Ultrasound-guided Blood Sampling With a Sterile and Dry Puncture Area
1 other identifier
interventional
10
1 country
1
Brief Summary
Thousands of vein punctures are done every day at hospitals worldwide. Vein puncture are performed in connection with blood sampling, peripheral intravenous catheter (PIV) placement or blood donation. The predominantly used venous for blood withdraw are in the cubital region because in this area venous are most superficial placed and most often visible for the human eye. However, when using the usual blind landmark and palpation method in this region, it often proves exceedingly difficult or even impossible to obtain peripheral venous access on patients who are obese, chronically ill, hypovolemic or intravenous drug users. Various studies have shown that the success rate for establishing a vascular access with ultrasound compared to blind landmark technique is higher in patients with difficult access. When ultrasound is used to establish intravascular access, the prerequisite sterile puncture area can be challenging to meet due to ultrasound gel on the area and the fact that the ultrasound transducer cannot be wiped clean with alcohol after being in contact with a patient's skin or blood. A strict sterile procedure is important to reduce complications related to infection.The traditional way of coping with this is by covering the transducer and the wire in a long sterile sheet and using sterile gel. The sheet must be tight with rubber band around the transducer and pulled tightly around the transducer foot to prevent artefacts from appearing on the screen. This is an expensive and time consuming method, and it still leaves the problem with gel in the puncture area. The investigators have developed a method by where all these problems are solved by using, a slightly modified, commercial drape in combination with the Dynamic Needle Tip Positioning technique The investigators hypothesize that it is possible to perform ultrasound-guided venous puncture with a sterile and dry puncture area and that puncture can be performed proximal and distal to the traditional puncture side. It is a procedure presenting study that serves to demonstrate the feasibility of the method in ten healthy volunteers. The study will take place at Aarhus University Hospital, Skejby.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Feb 2013
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
February 1, 2013
CompletedStudy Start
First participant enrolled
February 1, 2013
CompletedFirst Posted
Study publicly available on registry
February 7, 2013
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2013
CompletedStudy Completion
Last participant's last visit for all outcomes
March 1, 2013
CompletedFebruary 7, 2013
February 1, 2013
28 days
February 1, 2013
February 5, 2013
Conditions
Outcome Measures
Primary Outcomes (1)
Number of successful blood withdrawals
During blood sampling
Secondary Outcomes (1)
Image quality with and without sterile cover
During blood sampling
Other Outcomes (4)
Number of skin penetrations needed to puncture the vein
During blood sampling
Unexpected difficulties with the sterilization procedure
during blood sampling
Number of posterior vessel wall punctures
during blood sampling
- +1 more other outcomes
Study Arms (1)
modified commercial drape Tegaderm (R)
EXPERIMENTALInterventions
We test if a product type of the modified commercial drape Tegaderm(R) can bee used when taking blood samples under the guidance af ultrasound. The drape is used to keep the puncture area sterile and clean of ultrasound gel.
Eligibility Criteria
You may qualify if:
- age between 18 and 70 years of age
- mentally competent
- of good health
You may not qualify if:
- age below 18 or above 70 years of age
- daily use of blood thinner medication
- suffering from a chronic illness that requires frequent blood withdrawals
- heart conditions or vascular diseases
- People known to experience vasovagal episodes when having blood samples taken
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Aarhus University Hospitallead
- Danish Cancer Societycollaborator
Study Sites (1)
Aarhus University Hospital, Skejby
Aarhus, 8200, Denmark
Study Officials
- STUDY DIRECTOR
Erik Sloth, Professor, MD
Aarhus University Hospital
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- NA
- Masking
- NONE
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Research year student
Study Record Dates
First Submitted
February 1, 2013
First Posted
February 7, 2013
Study Start
February 1, 2013
Primary Completion
March 1, 2013
Study Completion
March 1, 2013
Last Updated
February 7, 2013
Record last verified: 2013-02